A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.
This study has been terminated.
(Due to the uncertain regulatory landscape for erythropoiesis-stimulating agents in oncology indications.)
Information provided by (Responsible Party):
First received: February 26, 2008
Last updated: November 29, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||June 2008|
|Primary Completion Date:||June 2008 (Final data collection date for primary outcome measure)|